8890OF |
Amphetamines Panel (Qualitative), Oral Fluid (Saliva) |
8891OF |
Benzodiazepines Panel (Qualitative), Oral Fluid (Saliva) |
8892OF |
Delta-9 THC (Qualitative), Oral Fluid (Saliva) |
8893OF |
Cocaine and Metabolites (Qualitative), Oral Fluid (Saliva) |
8894OF |
Methadone and Metabolite (Qualitative), Oral Fluid (Saliva) |
8895OF |
Opiates (Qualitative), Oral Fluid (Saliva) |
8896OF |
Phencyclidine and Dextromethorphan (Qualitative), Oral Fluid (Saliva) |
8897OF |
Drugs of Abuse (7 Panel) (Qualitative), Oral Fluid (Saliva) |
8898OF |
Drugs of Abuse (6 Panel) (Qualitative), Oral Fluid (Saliva) |
8900OF |
Delta-9 THC (Quantitative), Oral Fluid (Saliva) |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9146UC |
Ethyl Glucuronide Screen, Umbilical Cord Tissue |
9351UC |
Basic Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9352UC |
Expanded Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |